Integral Derivatives’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
Integral Derivatives's NVS Position: Q3 2015 in Review
Integral Derivatives sold out of Novartis (NVS) in Q3 2015, closing a stake of 5,452 shares — an estimated $480K sold.
Integral Derivatives first reported a position in NVS in Q1 2015 and held it in 2 quarters. The position peaked at $570K in Q1 2015. 926 funds tracked by Wall St. Rank hold NVS as of Q3 2015.
- Integral Derivatives reported no remaining Novartis position as of Q3 2015 after selling out during the quarter.
- Integral Derivatives sold 5,452 Novartis shares in Q3 2015, an estimated $480K.
- Integral Derivatives first reported a position in Novartis in Q1 2015 and held it in 2 quarters.
- Integral Derivatives's Novartis position peaked at $570K in Q1 2015.
- 926 funds tracked by Wall St. Rank held Novartis as of Q3 2015.
Based on Integral Derivatives's 13F filing for Q3 2015, filed 15 Oct 2015.